INTRODUCTION
Esophagitis, gastritis, duodenitis and gastrointestinal reflux disease (GERD) are common upper gastrointestinal disorders in the chronic kidney disease (CKD).
1-4 However, little is known about the prevalence of GERD in dialysis patients.
In a single-center survey, the prevalence of GERD was higher in hemodialysis patients than that in the general population. [5] [6] [7] [8] [9] [10] A previous study reported that the prevalence of GERD was higher in peritoneal dialysis patients than that in hemodialysis patients and in the general population.
However, the study included patients who were diagnosed using only clinical symptoms.
11
The effect of intraperitoneal pressure (IPP) on GERD in per- In contrast, a manometric study showed no effect of dialysate infusion on lower esophageal sphincter pressures due to transient relaxation of lower esophageal sphincter function.
13
The aim of this study was to determine the differences in the prevalence of erosive reflux esophagitis (ERD) and nonerosive reflux esophagitis (NERD) between CKD patients undergoing peritoneal dialysis and those undergoing hemodialysis.
SUBJECTS AND METHODS
The study was performed in accordance with the Declaration of Helsinki, and good clinical practice and applicable regulatory requirements. This study was approved by the Konyang University College of Medicine Institutional
Review Board (IRB 10-28).
Study design and patient population
From July 2010 to August 2011, patients with CKD undergoing peritoneal dialysis (peritoneal dialysis patients, n=40) and those undergoing hemodialysis (hemodialysis patients, n=43) for over 1 year were enrolled in this study. Fifteen patients were excluded from the study due to not meeting the inclusion criteria (7 patients) and declining to participate (8 patients). The following patients were excluded from the study: (1) those with a history of abdominal surgery; (2) those treated with a proton pump inhibitor within the past 1 month;
and (3) those with eradication of Helicobacter pylori. A total of 68 patients were enrolled (peritoneal dialysis patients, n=30, hemodialysis patients, n=38). There were 34 males and 34 females, and the mean age of the patients was 56.3±10.7 years.
Questionnaire
The prevalences of GERD in peritoneal dialysis and hemodialysis patients were assessed at a single center with endoscopic findings and face-to-face interviews using a validated symptom questionnaire previously used in the general population. 8 The questionnaire was completed by the patients.
Esophagogastric examinations
Each patient underwent upper gastrointestinal endoscopic examination, which was performed by a single well-trained gastroenterologist with at least 10 years of endoscopy experience. ERD was classified according to the Los Angeles classification into grades A to D. Minimal changes, such as erythema, increased vascularity, friability and edema, 14 were excluded from ERD.
Patients were diagnosed with NERD if heartburn or acid regurgitation was the most bothersome symptom at a frequency of at least once per week in the absence of ERD.
The CLO TM test (ASAN Pharm., Seoul, Korea) for H. pylori infection was performed.
Statistical analysis
Data are presented as mean±SD unless otherwise indicated. 
RESULTS

Characteristics of the patients at baseline
A total of 68 patients with CKD were divided into 2 groups:
those who underwent peritoneal dialysis (n=30) and those who underwent hemodialysis (n=38). Peritoneal dialysis and hemodialysis patients showed similar numbers of females (43% vs. 55%) and age ranges (55.0±11.6 years vs.
57.0±9.9 years).
The most common etiology of CKD was diabetic nephropathy (n=36, 52.9%), followed by hypertensive nephropathy (n=20, 29.4%), glomerulonephritis (n=5, 7.4%), polycystic kidney disease (n=2, 2.9%) and other etiologies (n=6, 8.8%).
The mean duration of dialysis was 67.1 (±46.8) months (Table 1) .
